{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:31:03Z","timestamp":1791318663631,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.cgh.2021.04.043","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T01:58:58Z","timestamp":1620007138000},"page":"569-577.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9483-5604","authenticated-orcid":false,"given":"Vivek C.","family":"Goodoory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yiannakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.04.043_bib1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.04.043_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2468-1253(20)30217-X","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis","volume":"5","author":"Oka","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.043_bib4","first-page":"159","article-title":"Identification of subgroups of functional intestinal disorders","volume":"3","author":"Drossman","year":"1990","journal-title":"Gastroenterol Int"},{"key":"10.1016\/j.cgh.2021.04.043_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S2468-1253(16)30023-1","article-title":"Pathophysiology of irritable bowel syndrome","volume":"1","author":"Holtmann","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.043_bib6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/01.meg.0000231755.42963.c6","article-title":"Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study","volume":"18","author":"Koloski","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.043_bib7","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","article-title":"The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study","volume":"61","author":"Koloski","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.04.043_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.cgh.2016.12.032","article-title":"Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population","volume":"15","author":"Jones","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.043_bib9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/apt.13738","article-title":"Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study","volume":"44","author":"Koloski","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.04.043_bib10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Development and validation of the Rome IV diagnostic questionnaire for adults","volume":"150","author":"Palsson","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib11","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","article-title":"Functional gastrointestinal disorders: advances in understanding and management","volume":"396","author":"Black","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.04.043_bib12","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/gutjnl-2020-322519","article-title":"Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care","volume":"70","author":"Black","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.04.043_bib15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41395-018-0074-z","article-title":"How the change in IBS criteria from Rome III to Rome IV impacts on clinical characteristics and key pathophysiological factors","volume":"113","author":"Aziz","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib16","doi-asserted-by":"crossref","first-page":"e13189","DOI":"10.1111\/nmo.13189","article-title":"Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study","volume":"30","author":"Vork","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2021.04.043_bib17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/jgh.13642","article-title":"Comparison of the Rome IV and Rome III criteria for IBS diagnosis: a cross-sectional survey","volume":"32","author":"Bai","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.043_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cgh.2019.05.037","article-title":"Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria","volume":"18","author":"Black","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.043_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13872","article-title":"Anxiety-related factors associated with symptom severity in irritable bowel syndrome","volume":"32","author":"Black","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2021.04.043_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.14309\/ajg.0000000000000975","article-title":"A\u00a0novel method to classify and subgroup patients with IBS based on gastrointestinal symptoms and psychological profiles","volume":"116","author":"Black","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14309\/ajg.0000000000000946","article-title":"Symptom stability in Rome IV vs Rome III irritable bowel syndrome","volume":"116","author":"Barberio","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cgh.2012.11.033","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis","volume":"11","author":"Sainsbury","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.043_bib23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis","volume":"5","author":"Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.043_bib24","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1053\/j.gastro.2018.01.027","article-title":"Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease","volume":"154","author":"Gracie","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41395-018-0021-z","article-title":"Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease","volume":"113","author":"Gracie","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pain.2007.08.029","article-title":"Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study","volume":"137","author":"Nicholl","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2021.04.043_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000121356","article-title":"Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study","volume":"26","author":"Bolling-Sternevald","year":"2008","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2021.04.043_bib28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/gut.41.3.394","article-title":"Predictors of health care seeking for irritable bowel syndrome: a population based study","volume":"41","author":"Talley","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.04.043_bib29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-2036.2003.01498.x","article-title":"Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia","volume":"17","author":"Koloski","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.04.043_bib30","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1111\/j.1572-0241.2002.05783.x","article-title":"Epidemiology and health care seeking in the functional GI disorders: a population-based study","volume":"97","author":"Koloski","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib31","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1053\/j.gastro.2018.08.021","article-title":"Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: systematic review and network meta-analysis","volume":"155","author":"Black","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41395-018-0026-7","article-title":"Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials","volume":"113","author":"Brenner","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/ajg.2017.41","article-title":"Tenapanor treatment of patients with constipation-predominant irritable bowel syndrome: a phase 2, randomized, placebo-controlled efficacy and safety trial","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib34","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2016.466","article-title":"Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis","volume":"112","author":"Irvine","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A\u00a0meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"Menees","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.043_bib37","doi-asserted-by":"crossref","first-page":"b3154","DOI":"10.1136\/bmj.b3154","article-title":"Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial","volume":"339","author":"Bijkerk","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2021.04.043_bib38","series-title":"Rome III: The functional gastrointestinal disorders","first-page":"835","article-title":"Development and validation of the Rome III diagnostic questionnaire","year":"2006"},{"key":"10.1016\/j.cgh.2021.04.043_bib39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Rome IV diagnostic questionnaires and tables for investigators and clinicians","volume":"150","author":"Palsson","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib40","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib41","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.043_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.04.043_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.cgh.2021.04.043_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2036.2010.04402.x","article-title":"The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease","volume":"32","author":"Spiller","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.04.043_bib45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","article-title":"The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms","volume":"64","author":"Kroenke","year":"2002","journal-title":"Psychosom Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521005012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521005012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:38:40Z","timestamp":1761543520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356521005012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1542356521005012"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.04.043","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute","name":"copyright","label":"Copyright"}]}}